FE 200 440: a selective oxytocin antagonist on the term‐pregnant human uterus

No abstract is available for this paper.

• Publication year

  2003

• Venue

  BJOG: an International Journal of Obstetrics and Gynaecology

• Publication date

  2003-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1471-0528.2003.02540.xPMID 14592588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitory effects of SR 49059 on oxytocin‐and vasopressin‐induced uterine contractions in non‐pregnant women

  2004cited by this paper
• Effectiveness and safety of the oxytocin antagonist atosiban versus beta‐adrenergic agonists in the treatment of preterm labour

  2001cited by this paper
• Spontaneous contractions of myometrium from humans, non‐human primate and rodents are sensitive to selective oxytocin receptor antagonism in vitro

  2001cited by this paper
• Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women

  1999cited by this paper
• Oxytocin receptor expression in human term and preterm gestational tissues prior to and following the onset of labour.

  1999cited by this paper
• Comparison of the In Vivo Activity of Different Oxytocin Antagonists in the Pregnant Baboon

  1998cited by this paper
• Oxytocin and vasopressin 1a receptor gene expression in the cycling or pregnant human uterus.

  1998cited by this paper
• Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin‐induced uterine contractions

  1997cited by this paper
• Receptor‐mediated uterine effects of vasopressin and oxytocin in nonpregnant women

  1995cited by this paper
• Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban.

  1994cited by this paper
• Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors.

  1990cited by this paper
• Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study

  1988cited by this paper
• Uterine blood flow and myometrial activity at menstruation, and the action of vasopressin and a synthetic antagonist

  1988cited by this paper
• Vasotocin analogues which competitively inhibit vasopressin stimulated uterine activity in healthy women

  1986cited by this paper
• Synthetic antagonists of the myometrial response to vasopressin and oxytocin.

  1986cited by this paper
• THE EFFECT ON THE HUMAN UTERUS OF TWO NEWLY DEVELOPED COMPETITIVE INHIBITORS OF OXYTOCIN AND VASOPRESSIN

  1985cited by this paper
• Vasopressin and Prostaglandins in Premenstrual Pain and Primary Dysmenorrhea

  1984cited by this paper
• Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor.

  1982cited by this paper
• PRIMARY DYSMENORRHOEA AND VASOPRESSIN

  1979cited by this paper
• EFFECTS OF TERBUTALINE ON MYOMETRIAL ACTIVITY, UTERINE BLOOD FLOW, AND LOWER ABDOMINAL PAIN IN WOMEN WITH PRIMARY DYSMENORRHOEA

  1976cited by this paper
• A Sensitive Hydroosmotic Toad Bladder Assay

  1968cited by this paper

• Oxytocin signaling in the treatment of drug addiction: Therapeutic opportunities and challenges.

  2021cites this paper
• Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists

  2020cites this paper
• Barusiban, a selective oxytocin receptor antagonist: placental transfer in rabbit, monkey, and human†

  2020cites this paper
• Design of Oxytocin Analogs.

  2019cites this paper
• Quantitative Structure-Activity Relationship Calculations in the Field of Oxytocin Receptor Antagonists

  2019cites this paper
• Oxytocin receptor antagonists and their clinical application

  2018cites this paper
• A patent review of oxytocin receptor antagonists 2013-2017

  2017influential citation
• Oxytocin receptor antagonists for inhibiting preterm labour.

  2014cites this paper
• Oxytocin receptor antagonists for inhibiting preterm labour.

  2014cites this paper
• Oxytocin: Its Mechanism of Action and Receptor Signalling in the Myometrium

  2014cites this paper
• The effect of combined tocolysis on in vitro uterine contractility in preterm labour.

  2011cites this paper
• The design of orally bioavailable 2, 5‐diketopiperazine oxytocin antagonists: from concept to clinical candidate for premature labor

  2011cites this paper
• Synthesis and biological activity of oxytocin analogues containing unnatural amino acids in position 9: structure activity study

  2010cites this paper
• Treatment efficacy of trimethoprim sulfamethoxazole, pentoxifylline and altrenogest in experimentally induced equine placentitis.

  2010cites this paper
• TREATMENT EFFICACY OF TRIMETHOPRIM SULFAMETHOXAZOLE , PENTOXIFYLLINE AND ALTRENOGEST IN EXPERIMENTALLY INDUCED EQUINE

  2009cites this paper
• The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial.

  2009cites this paper
• Oxytocin receptor ligands: a survey of the patent literature

  2008cites this paper
• Emerging tocolytics: challenges in designing and testing drugs to delay preterm delivery and prolong pregnancy.

  2008cites this paper
• Oxytocin receptors: ligand binding, signalling and cholesterol dependence.

  2008cites this paper
• Emerging tocolytics: challenges in designing and testing drugs to delay preterm delivery and prolong pregnancy

  2008cites this paper
• Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.

  2008cites this paper
• The present and future of tocolysis

  2007cites this paper
• Expression of the oxytocin gene, but not the vasopressin gene, in the rat uterus during pregnancy: influence of oestradiol and progesterone.

  2007cites this paper
• Barusiban suppresses oxytocin-induced preterm labour in non-human primates

  2007cites this paper
• Overview. Preterm labour: mechanisms and management

  2007cites this paper
• Modeling the human oxytocin receptor for drug discovery efforts

  2007cites this paper
• Barusiban, An Effective Long-Term Treatment of Oxytocin-Induced Preterm Labor in Nonhuman Primates1

  2006influential citation
• CHAPTER 58 – Oxytocin: Synthesis, Secretion, and Reproductive Functions

  2006cites this paper
• Targeting the oxytocin receptor to relax the myometrium

  2006cites this paper
• Oxytocin Antagonists and Agonists

  2006cites this paper
• Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin.

  2005cites this paper
• Barusiban, a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor.

  2005cites this paper
• Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban

  2005cites this paper
• What's new and novel in obstetric anesthesia? Contributions from the 2003 scientific literature.

  2005cites this paper
• Frequently asked questions on tocolytics

  2005cites this paper
• Preterm Labour: Biology of preterm labour

  2005cites this paper
• Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP).

  2004cites this paper
• In vivo activity of the potent oxytocin antagonist on uterine activity in the rat.

  2004cites this paper
• The Gordian Knot of Developing Tocolytics

  2004cites this paper
• Inhibitory Effect of Barusiban and Atosiban on Oxytocin-Induced Contractions of Myometrium From Preterm and Term Pregnant Women

  2004cites this paper